Prime Islami Life Insurance Limited announcements
319 Dhaka Stock Exchange announcements for Prime Islami Life Insurance Limited (PRIMELIFE) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2026 (18).
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2025 to the respective shareholders.
- Q3 Financials
(Q3 Un-audited): As per life revenue account of the company for July to September, 2026, excess of total expenses including claims over total income (deficit) was BDT 607.89 million as against excess of total expenses including claims over total income (deficit) of BDT 70.42 million in the corresponding previous period of 2025. Whereas as per life revenue account of the company for January to September, 2026, excess of total expenses including claims over total income (cont.) (Continuation news of PRIMELIFE): (deficit) was BDT 1,206.17 million as against excess of total expenses including claims over total income (deficit) of BDT 1,021.17 million in the corresponding previous period of 2025. Accordingly, Balance of Life Insurance Fund was BDT 6,190.84 million as on September 30, 2026 as against BDT 6,470.73 million as on September 30, 2025 resulting a net decrease of BDT 279.89 million. (end)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2026 at 3:30 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended September 30, 2026.
- Update of Information
The company has requested to update the Bank Accounts, Address, Mobile number, 12 digits e-TIN number through their respective DP as per Record Date 16/07/2026. The company has also requested the Merchant Banks and Brokerage Houses to provide a statement with details (Shareholders' name, BO ID number, 12-digit e-TIN Number, (cont.) (Cont. News of PRIMELIFE): Number of shares held, Gross dividend receivable, applicable tax rate) of their margin loan holders who hold shares of the Company on the record date along with the name and mobile number of the contact person within July 30, 2026 and soft data to the e-mail address: [email protected]. (end)
- Resumption after Record Date
Trading of the shares of the company will resume on 19.07.2026.
- Q2 Financials
(Q2 Un-audited): As per consolidated life revenue account of the company for April to June, 2026, excess of total expenses including claims over total income (deficit) was BDT 21.59 million as against excess of total expenses including claims over total income (deficit) of BDT 206.22 million in the corresponding previous period of 2025. Whereas as per consolidated life revenue account of the company for January to June, 2026, excess of total expenses including claims over total income (deficit) (cont.) (Continuation news of PRIMELIFE): was BDT 598.27 million as against excess of total expenses including claims over total income (deficit) of BDT 950.75 million in the corresponding previous period of 2025. Balance of Life Insurance Fund was BDT 6,798.74 million as on June 30, 2026 as against BDT 6,541.15 million as on June 30, 2025 resulting a net increase of BDT 257.59 million. (end)
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 16.07.2026.
- Disclosure regarding Valuation Report as at December 31, 2024
The board of directors of the company has approved valuation report as at December 31, 2024. As per the valuation report, the Net Liability stood at Tk. 13,469,059,320.00 as at December 31, 2024 as against Tk. 14,267,801,247.00 as at December 31, 2023. The Balance of Life Insurance Fund as shown in the balance sheet was Tk. 7,491,907,036.00 as at December 31, 2024 as against Tk. 7,573,495,801.00 as at December 31, 2023. (cont.) (Cont. News of PRIMELIFE): The company reported a deficit of Tk. 5,977,152,284.00 as at December 31, 2024 as against a Deficit of Tk. 6,694,305,446.00 as at December 31, 2023. (end)
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 14.07.2026 to 15.07.2026 and trading of the shares will remain suspended on record date i.e., 16.07.2026.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 14, 2026 at 3:30 pm to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended June 30, 2026.
- Qualified Opinion, Emphasis of Matter and Other Matters
The auditor of the company has given the Qualified Opinion, Emphasis of Matter and Other Matters paragraph in the auditor's report for the year ended December 31, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/PRIMELIFE.pdf
- Dividend Declaration
The Board of Directors has recommended 0.25% Cash Dividend for the year ended December 31, 2025. Date of AGM: 17.09.2026, Time: 10:30 AM, Mode: Hybrid System. Venue: Sena Gourab Hall, SKS Tower (Level-9), Sena Convention Hall, 7, VIP Road, Mohakhali, Dhaka- 1206. Record Date: 16.07.2026.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (16.06.2026) following its corporate declaration.
- Q1 Financials
(Q1 Un-audited): As per consolidated life revenue account of the company for January to March, 2026, excess of total expenses including claims over total income (deficit) was BDT 576.67 million as against excess of total expenses including claims over total income (deficit) of BDT 744.53 million in the corresponding previous period of 2025. (cont.) (Continuation news of PRIMELIFE): Balance of Life Insurance Fund was BDT 6,820.33 million as on March 31, 2026 as against BDT 6,747.37 million as on March 31, 2025 resulting a net increase of BDT 72.96 million. (end)
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 15, 2026 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2025.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 15, 2026 at 3:30 pm to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended March 31, 2026.
- Valuation report as at 31st December 2023
The company has informed that the Board of Directors of the company in its 227th meeting held on April 09, 2026 has taken the following decision among others: The valuation report 2023 has been approved by the Board of Directors as follows: Net Liability as at 31st December 2023: 14,267,801,247/- as against 14,325,680,024/- as at 31st December 2022; (cont.) (Cont. news of PRIMELIFE): Balance of Life Insurance Fund as shown in the balance sheet as at 31st December 2023: 7,573,495,801/- as against 7,713,332,660/- as at 31st December 2022; Surplus (+)/Deficit (-) as at 31st December 2023: (-) 6,694,305,446/- as against (-)6,612,347,364/- as at 31st December 2022. (end)
- Credit Rating Result
Alpha Credit Rating PLC (Alpha Rating) has assigned the Surveillance rating of the Company as "A+" in the long term and "ST-2" in the short term along with Stable outlook based on the audited financial statements up to December 31, 2024 and relevant qualitative information till February 22, 2026.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.